Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R and the EUROCARE-6 Working Group (2023)
Front. Oncol. 2023; 13:1114701.doi: 10.3389/fonc.2023.1114701
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
Botta L, Gatta G, Capocaccia R, Stiller C, Cañete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, Lacour B, Marcos-Gragera R, Murray D, Rossi S; EUROCARE-6 Working Group.
Lancet Oncol. 2022 Dec;23(12):1525-1536. doi: 10.1016/S1470-2045(22)00637-4. Epub 2022 Nov 16.
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.
Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M, the EUROCARE-6 Working Group.
Frontiers in Oncology 2022; 12, Article 892684. doi:10.3389/fonc.2022.892684
Progetto Eurocare
Pubblicazioni